Restricted Palivizumab Recommendations and the Impact on RSV Hospitalizations among Infants Born at > 29 Weeks of Gestational Age: An Italian Multicenter Study
Conclusion Restricting eligibility for palivizumab reimbursement led to a significant increase in RSVH but had no impact on hospitalizations for other respiratory viruses. Future decisions on palivizumab prescription and coverage rules should be driven by a careful assessment of the cost-benefit ratio. [...] Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Article in Thieme eJournals: Table of contents | Abstract | Full text
Source: American Journal of Perinatology - Category: Perinatology & Neonatology Authors: Priante, Elena Tavella, Elena Girardi, Elisa Militello, Maria Angela Mardegan, Veronica Maule, Milena M. Dall'Agnola, Alberto Baraldi, Eugenio Manzoni, Paolo Tags: Original Article Source Type: research
More News: Epidemics | Epidemiology | Intensive Care | Italy Health | Perinatology & Neonatology | Respiratory Medicine | Study